Advertisement
Advertisement
PTN
Palatin Technologies, Inc.
21.00
USDSponsored
+1.15
+5.78%
Mar 25, 16:00 UTC -4
Closed
After-Market
21.04
+0.04
+0.20%
PTN Earnings Reports
Positive Surprise Ratio
PTN beat 18 of 37 last estimates.
49%
Next Report
Date of Next Report
May 12, 2026
Estimate for Q3 26 (Revenue/ EPS)
$1.30M
/-$1.25
Implied change from Q2 26 (Revenue/ EPS)
+1017.38%
/-56.29%
Implied change from Q3 25 (Revenue/ EPS)
--
/-86.11%
Palatin Technologies, Inc. earnings per share and revenue
On Feb 17, 2026, PTN reported earnings of -2.86 USD per share (EPS) for Q2 26, missing the estimate of -2.37 USD, resulting in a -20.32% surprise. Revenue reached 116.00 thousand, compared to an expected 50.50 thousand, with a 129.70% difference. The market reacted with a +1.15% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 4 analysts forecast an EPS of -1.25 USD, with revenue projected to reach 1.30 million USD, implying an decrease of -56.29% EPS, and increase of 1017.38% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Dyadic International, Inc.
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.04
Actual
-$0.06
Surprise
-30.72%
TELA Bio, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.18
Actual
-$0.16
Surprise
+14.12%
BioCardia, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.17
Actual
-$0.06
Surprise
+65.40%
Celcuity Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$1.06
Actual
-$0.97
Surprise
+8.72%
Precigen, Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.01
Surprise
+88.24%
Absci Corporation Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.23
Surprise
-16.04%
Candel Therapeutics, Inc. Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
-$0.25
Actual
-$0.54
Surprise
-115.31%
LENZ Therapeutics, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.99
Actual
-$1.15
Surprise
-17.10%
Fennec Pharmaceuticals Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
$0.03
Actual
-$0.11
Surprise
-408.12%
Equillium, Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.06
Actual
-$0.04
Surprise
+35.28%
FAQ
What were Palatin Technologies, Inc.'s earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Palatin Technologies, Inc. reported EPS of -$2.86, missing estimates by -20.32%, and revenue of $116.00K, 129.7% above expectations.
How did the market react to Palatin Technologies, Inc.'s Q2 2026 earnings?
The stock price moved up 1.15%, changed from $17.39 before the earnings release to $17.59 the day after.
When is Palatin Technologies, Inc. expected to report next?
The next earning report is scheduled for May 12, 2026.
What are the forecasts for Palatin Technologies, Inc.'s next earnings report?
Based on 4
analysts, Palatin Technologies, Inc. is expected to report EPS of -$1.25 and revenue of $1.30M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement